Cite

    , . et al. (n.d.). 33 Cetuximab paying toll to improve its therapeutic efficacy – Improving cetuximab-mediated head and neck cancer treatment via co-activation of Fc-receptors and toll-like receptors. Oral oncology. 51 (5), pp. e37-. [Online].